Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lentiviruses as gene delivery vectors.

M Federico1

  • 1Laboratory of Virology Istituto Superiore di Sanità Viale Regina Elena 299 00161, Rome, Italy. federico@virus1.net.iss.it

Current Opinion in Biotechnology
|October 6, 1999
PubMed
Summary

Lentivirus vectors show promise for gene delivery across various tissues, including recent advances in human hematopoietic progenitor cells. Despite progress with HIV-1 and HIV-2 based vectors, challenges in lentiviral gene therapy persist.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nerve-sparing total prostatectomy with or without adjuvant chemotherapy is associated with a low rate of surgical complications, long-term continence and improved survival in 22 dogs with T1 to T3 prostatic tumours.

The Journal of small animal practice·2026
Same author

Peripheral T- and natural killer-cell lymphomas: ESMO-EHA Clinical Practice Guideline for diagnosis, treatment and follow-up.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

Oligometastatic sarcoma treated with Curative intent Ablative Radiotherapy (OSCAR): A multicenter study on behalf of AIRO (Italian association of Radiotherapy and clinical Oncology).

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2024
Same author

Stereotactic Body Radiotherapy for Spine Oligometastases: A Multicentre Retrospective Study From the Italian Association of Radiotherapy and Clinical Oncology (AIRO).

Clinical oncology (Royal College of Radiologists (Great Britain))·2023
Same author

Hodgkin lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Annals of oncology : official journal of the European Society for Medical Oncology·2018
Same author

International Working Group consensus response evaluation criteria in lymphoma (RECIL 2017).

Annals of oncology : official journal of the European Society for Medical Oncology·2017

Area of Science:

  • Biotechnology
  • Gene Therapy
  • Virology

Background:

  • Lentivirus vectors are established gene delivery tools for diverse cell types like liver, retina, skeletal muscle, and central nervous system.
  • Recent advancements include successful gene transfer experiments in human hematopoietic progenitor cells.

Purpose of the Study:

  • To review the current applications and recent progress in lentivirus vector technology.
  • To highlight new generations of human immunodeficiency virus type 1 (HIV-1) and human immunodeficiency virus type 2 (HIV-2) based lentivirus vectors.
  • To identify persistent challenges in the field of lentiviral gene delivery.

Main Methods:

  • Review of recent scientific literature on lentivirus vector applications.
  • Description of novel lentivirus vector designs, including those based on HIV-1 and HIV-2.
  • Analysis of gene transfer efficiency and safety data in various cell types.

Main Results:

  • Lentivirus vectors are effective for gene delivery in liver, retina, skeletal muscle, and central nervous system cells.
  • Significant progress has been made in gene transfer into human hematopoietic progenitor cells.
  • Newer generations of HIV-1 based vectors and potentially safer HIV-2 based vectors have been developed.

Conclusions:

  • Lentivirus vectors continue to be a powerful tool for gene therapy applications.
  • Ongoing research is expanding the utility of lentivirus vectors, particularly in hematopoietic stem cell gene therapy.
  • Further research and development are necessary to overcome existing obstacles for widespread clinical application of lentivirus vectors.

Related Experiment Videos